National Guideline Clearinghouse | Third-line therapy for patients with type 2 diabetes inadequately controlled with metformin and a sulfonylurea.

Guideline Title

Third-line therapy for patients with type 2 diabetes inadequately controlled with metformin and a sulfonylurea.

Bibliographic Source(s)
CADTH Therapeutic Review Panel. Third-line therapy for patients with type 2 diabetes inadequately controlled with metformin and a sulfonylurea. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health (CADTH); 2010 Aug. 18 p. [57 references]

Guideline Status
This is the current release of the guideline.


full-text:
National Guideline Clearinghouse | Third-line therapy for patients with type 2 diabetes inadequately controlled with metformin and a sulfonylurea.